Skip to main content
Livermore
Livermore
ZHEN

Ultragenyx Pharmaceutical Inc.

RARE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001515673

In the last 90 days, Ultragenyx Pharmaceutical Inc. insiders filed 0 open-market purchases and 4 sales; 311 institutions reported holding it in 13F filings for Q2 2026, worth $3.55B in total; no superinvestor holds it.

Q4 2024 vs. Q3 2024

How the institutions holding Ultragenyx Pharmaceutical Inc. changed between Q3 2024 and Q4 2024.

All holders in Q4 2024All holders in Q3 2024

13F holders of RARE: Q3 2024 compared with Q4 2024
MeasureQ3 2024Of which not filed for Q4 2024Q4 2024Change
Holders3022314+14
Shares86.9M44.1K87.5M+635.4K (+0.7%)
Value$4.83B$2.45M$3.68B−$1.14B (−23.7%)

2 institutions that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (56)

Institutions that held Ultragenyx Pharmaceutical Inc. at the end of Q4 2024 but not at the end of Q3 2024.

Institutions new to RARE in Q4 2024
InstitutionSharesValue% of portfolio
Deep Track Capital, LP653,513$27.5M1.03%
Fisher Asset Management, LLC265,189$11.2M0.00%
Universal- Beteiligungs- und Servicegesellschaft mbH130,853$5.50M0.01%
Silverarc Capital Management, LLC124,388$5.23M1.17%
Balyasny Asset Management LLC109,900$4.62M0.01%
StemPoint Capital LP101,809$4.28M1.07%
Squarepoint Ops LLC87,989$3.70M0.01%
ExodusPoint Capital Management, LP87,017$3.66M0.04%
F/M Investments LLC42,004$1.77M0.07%
Campbell & CO Investment Adviser LLC39,694$1.67M0.13%
Police & Firemen's Retirement System of New Jersey33,282$1.40M0.01%
Crestline Management, LP27,949$1.18M0.04%
Axq Capital, LP23,077$970.8K0.44%
Raymond James Financial Inc21,774$916.0K0.00%
Simplify Asset Management Inc.16,810$707.2K0.05%
KLP Kapitalforvaltning AS16,300$685.7K0.00%
Birchview Capital, LP16,000$673.1K0.55%
Dark Forest Capital Management LP10,916$459.2K0.07%
Bryce Point Capital, LLC10,719$450.9K0.13%
Sherbrooke Park Advisers LLC10,387$437.0K0.14%
Fieldview Capital Management, LLC8,294$348.9K0.05%
ADAR1 Capital Management, LLC8,000$336.6K0.07%
B Group, Inc.7,596$319.6K0.20%
Syon Capital LLC7,362$309.7K0.03%
EntryPoint Capital, LLC6,939$291.9K0.12%
Magnetar Financial LLC6,779$285.2K0.01%
Quantinno Capital Management LP5,013$210.9K0.00%
denkapparat Operations GmbH4,912$206.6K0.31%
Bayforest Capital Ltd3,144$132.3K0.17%
R Squared Ltd2,460$103.5K0.10%
Quarry LP2,000$84.1K0.02%
GF Fund Management Co. Ltd.1,939$81.6K0.00%
Leonteq Securities AG1,510$63.5K0.01%
PEAK6 LLC1,093$46.0K0.00%
Human Investing LLC1,000$42.1K0.01%
Caitong International Asset Management Co., Ltd899$37.8K0.04%
Aster Capital Management (DIFC) Ltd825$34.7K0.01%
Nelson, Van Denburg & Campbell Wealth Management Group, LLC283$11.9K0.00%
Skopos Labs, Inc.205$8.63K0.00%
Hexagon Capital Partners LLC93$3.91K0.00%
WPG Advisers, LLC88$3.70K0.00%
MAI Capital Management53$2.23K0.00%
Sierra Ocean, LLC29$1.22K0.00%
Bogart Wealth, LLC23$9680.00%
Creative Planning21$8830.00%
Quantbot Technologies LP16$6730.00%
EverSource Wealth Advisors, LLC13$5470.00%
Whipplewood Advisors, LLC13$5470.00%
IFP Advisors, Inc0$5050.00%
Cassady Schiller Wealth Management, LLC10$4210.00%
Principal Securities, Inc.7$2940.00%
Parkside Financial Bank & Trust6$2530.00%
Assetmark, Inc6$2520.00%
Principia Wealth Advisory, LLC6$2520.00%
SBI Securities Co., Ltd.1$420.00%
Activest Wealth Management1$420.00%

Sold out (42)

Institutions that held Ultragenyx Pharmaceutical Inc. at the end of Q3 2024 and filed for Q4 2024 without it.

Institutions that sold out of RARE in Q4 2024
InstitutionShares, Q3 2024Value, Q3 2024
Cubist Systematic Strategies, LLC183,490$10.2M
Jacobs Levy Equity Management, Inc97,960$5.44M
EAM Investors, LLC58,631$3.26M
Tudor Investment Corp Et Al54,496$3.03M
Voloridge Investment Management, LLC52,266$2.90M
NEOS Investment Management LLC45,599$2.53M
Seven Eight Capital, LP35,478$1.97M
Cerity Partners LLC31,919$1.77M
Savant Capital, LLC22,888$1.27M
Natixis15,671$870.5K
Capstone Investment Advisors, LLC13,089$727.1K
Headlands Technologies LLC12,052$669.5K
Gsa Capital Partners LLP11,508$639.0K
Captrust Financial Advisors11,428$634.8K
Pallas Capital Advisors LLC10,904$597.8K
Ieq Capital, LLC8,434$468.5K
Fifth Lane Capital, LP6,917$384.2K
Benjamin Edwards Inc6,084$338.0K
Angeles Investment Advisors, LLC5,911$328.4K
ProShare Advisors LLC5,885$326.9K
Dynasty Wealth Management, LLC5,209$289.4K
Corton Capital Inc.5,099$283.2K
Colony Group, LLC5,005$278.0K
Atria Investments LLC4,836$268.6K
Altfest L J & Co Inc4,565$254.0K
Valence8 US LP4,241$235.6K
Farallon Capital Management, L.L.C.4,000$222.2K
Nan Fung Group Holdings Ltd3,820$212.2K
International Assets Investment Management, LLC10,388$187.0K
nVerses Capital, LLC2,700$150.0K
Allspring Global Investments Holdings, LLC2,287$127.0K
Capital Performance Advisors LLP1,934$107.4K
Acadian Asset Management LLC1,692$93.0K
Nomura Asset Management Co Ltd1,669$92.7K
Values First Advisors, Inc.1,010$56.1K
True Wealth Design, LLC778$43.2K
Groupama Asset Managment948$42.3K
NBC Securities, Inc.159$8.00K
GWM Advisors LLC102$5.67K
Whittier Trust Co of Nevada Inc70$3.89K
Northwestern Mutual Wealth Management Co22$1.22K
Ronald Blue Trust, Inc.6$247

Not filed for Q4 2024 yet (2)

Institutions that held Ultragenyx Pharmaceutical Inc. at the end of Q3 2024 and haven't filed a 13F for Q4 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding RARE in Q3 2024 that haven't filed for Q4 2024
InstitutionShares, Q3 2024Value, Q3 2024
B. Metzler seel. Sohn & Co. Holding AG23,817$1.32M
Raymond James & Associates20,266$1.13M